Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial†-Reference-Cited by-同舟云学术

Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial†

Published:2009-10-29 Issue:11 Volume:11 Page:1099-1105
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Adamopoulos Chris¹,Ahmed Ali²,Fay Renaud¹,Angioi Michael¹³,Filippatos Gerasimos⁴,Vincent John⁵,Pitt Bertram⁶,Zannad Faiez¹³,

Affiliation:

1. Inserm, Centre d'Investigations Cliniques CIC Inserm CHU and U961, Hôpital Jeanne d’ Arc; Toul 54200 France

2. University of Alabama at Birmingham and VA Medical Center; Birmingham AL USA

3. Hypertension and Heart Failure Division, Department of Cardiovascular Disease; Hôpital Jeanne d’ Arc; Nancy France

4. Department of Cardiology; Athens University Hospital Attikon; Athens Greece

5. Pfizer Inc.; New York NY USA

6. University of Michigan; Ann Arbor MI USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction;Beygui;Circulation,2006

2. Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction;Hayashi;J Am Coll Cardiol,2001

3. Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction;Palmer;Eur Heart J,2008

4. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction;Hayashi;Circulation,2003

5. Eplerenone a selective aldosterone blocker in patients with left ventricular dysfunction after myocardial infarction;Pitt;N Engl J Med,2003

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological and Device-Based Intervention for Preventing Heart Failure After Acute Myocardial Infarction　― A Clinical Review ―;Circulation Journal;2024-09-13

2. Guía latinoamericana de recomendaciones al egreso de un síndrome coronario agudo;Archivos de Cardiología de México;2024-06-05

3. Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines;Cardiovascular Therapy and Prevention;2024-04-01

4. The spectrum of post-myocardial infarction care: From acute ischemia to heart failure;Progress in Cardiovascular Diseases;2024-01

5. Heart Failure After Acute Myocardial Infarction: A New Phenotype of Acute Heart Failure?;ABC Heart Fail Cardiomyop;2023